- Report
- December 2024
- 150 Pages
Global
From €4328EUR$4,850USD£3,748GBP
- Report
- November 2024
- 150 Pages
Global
From €4328EUR$4,850USD£3,748GBP
- Report
- September 2024
- 150 Pages
Global
From €4328EUR$4,850USD£3,748GBP
- Report
- January 2025
- 37 Pages
Global
From €2230EUR$2,499USD£1,931GBP
- Report
- January 2024
Global
From €3213EUR$3,600USD£2,782GBP
- Report
- January 2024
Middle East, Africa
From €1339EUR$1,500USD£1,159GBP
- Report
- March 2025
- 150 Pages
Global
From €4328EUR$4,850USD£3,748GBP
- Report
- October 2025
- 88 Pages
Philippines
From €4328EUR$4,850USD£3,748GBP
- Report
- November 2023
- 91 Pages
Europe
From €3079EUR$3,450USD£2,666GBP
- Report
- November 2023
- 165 Pages
Global
From €4417EUR$4,950USD£3,825GBP
- Report
- August 2023
- 180 Pages
Global
From €3346EUR$3,750USD£2,898GBP
- Report
- August 2023
- 180 Pages
Global
From €3346EUR$3,750USD£2,898GBP
- Report
- June 2020
- 294 Pages
Global
From €7362EUR$8,250USD£6,376GBP
- Report
- October 2023
- 146 Pages
Global
From €3148EUR$3,528USD£2,726GBP
€3703EUR$4,150USD£3,207GBP
- Report
- February 2026
- 100 Pages
Global
From €3500EUR$4,201USD£3,137GBP
- Report
- February 2026
- 105 Pages
Global
From €3500EUR$4,201USD£3,137GBP
- Report
- February 2026
- 90 Pages
Global
From €3500EUR$4,201USD£3,137GBP
- Report
- March 2024
- 122 Pages
Global
From €3500EUR$4,201USD£3,137GBP
- Report
- February 2026
- 73 Pages
Global
From €3500EUR$4,201USD£3,137GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more